Surrogate Endpoints for Pulmonary Hypertension Management and Trial Design: Moving in the Right Direction

J Am Coll Cardiol. 2018 Feb 20;71(7):764-765. doi: 10.1016/j.jacc.2017.12.029.
No abstract available

Keywords: morbidity; mortality; pulmonary hypertension; surrogate endpoints.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Biomarkers
  • Familial Primary Pulmonary Hypertension
  • Humans
  • Hypertension*
  • Hypertension, Pulmonary*
  • Prognosis

Substances

  • Biomarkers